Parnell CEO to present at Jefferies conference; CutisPharma names new CEO; West Pharmaceutical insider sells stock;

Parnell Pharmaceuticals Holdings ($PARN) President and CEO, Robert Joseph, will be presenting at the Jefferies 2015 Healthcare Conference in New York next week. Release

CutisPharma, a specialty pharmaceutical company that develops and distributes bulk drugs in kits used by pharmacists to create compounded medications, has named Neal Muni as its CEO. Release

Karen Flynn, a West Pharmaceutical Services president, sold 3,091 shares of company stock last week at an average price of $55.24 for a total transaction of $170,746.84. Article